Local Pharma API companies to gain from Rs 10,000 crore scheme

The incentive — part of a .`10,000-crore production-linked incentive scheme to boost domestic manufacturing of critical bulk drugs and APIs approved by the Cabinet in March — will be given to companies investing on greenfield plants to manufacture 53 crucial APIs.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2BoEVf6
via IFTTT